These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate - The effect of vaginal pH on drug carrier performance. Szymańska E; Wojasiński M; Dąbrowska J; Krzyżowska M; Nowicka M; Ciach T; Winnicka K Int J Biol Macromol; 2022 Dec; 222(Pt A):856-867. PubMed ID: 36174868 [TBL] [Abstract][Full Text] [Related]
67. The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue. Hu M; Zhou T; Dezzutti CS; Rohan LC AIDS Res Hum Retroviruses; 2016; 32(10-11):992-1004. PubMed ID: 27611224 [TBL] [Abstract][Full Text] [Related]
68. In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems. Blakney AK; Little AB; Jiang Y; Woodrow KA Drug Deliv; 2016 Nov; 24(1):582-590. PubMed ID: 28222612 [TBL] [Abstract][Full Text] [Related]
69. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model. Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161 [TBL] [Abstract][Full Text] [Related]
70. Relationships between mechanical properties and drug release from electrospun fibers of PCL and PLGA blends. Chou SF; Woodrow KA J Mech Behav Biomed Mater; 2017 Jan; 65():724-733. PubMed ID: 27756048 [TBL] [Abstract][Full Text] [Related]
71. Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections. Vuong HR; Tyo KM; Steinbach-Rankins JM J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155732 [TBL] [Abstract][Full Text] [Related]
72. Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties. Coulibaly FS; Ezoulin MJM; Purohit SS; Ayon NJ; Oyler NA; Youan BC Mol Pharm; 2017 Oct; 14(10):3512-3527. PubMed ID: 28830144 [TBL] [Abstract][Full Text] [Related]
73. Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry. Herold BC; Scordi-Bello I; Cheshenko N; Marcellino D; Dzuzelewski M; Francois F; Morin R; Casullo VM; Anderson RA; Chany C; Waller DP; Zaneveld LJ; Klotman ME J Virol; 2002 Nov; 76(22):11236-44. PubMed ID: 12388683 [TBL] [Abstract][Full Text] [Related]
74. Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates. Patel SK; Agashe H; Patton DL; Sweeney Y; Beamer MA; Hendrix CW; Hillier SL; Rohan LC Front Reprod Health; 2023; 5():1217835. PubMed ID: 37638127 [TBL] [Abstract][Full Text] [Related]
75. Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females. Tan D Int J Womens Health; 2012; 4():341-50. PubMed ID: 22927765 [TBL] [Abstract][Full Text] [Related]
76. Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Ham AS; Cost MR; Sassi AB; Dezzutti CS; Rohan LC Pharm Res; 2009 Mar; 26(3):502-11. PubMed ID: 19002569 [TBL] [Abstract][Full Text] [Related]
77. Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones. Li L; Gatto GJ; Brand RM; Krovi SA; Cottrell ML; Norton C; van der Straten A; Johnson LM J Control Release; 2021 Dec; 340():188-199. PubMed ID: 34678316 [TBL] [Abstract][Full Text] [Related]
78. Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis. Notario-Pérez F; Galante J; Martín-Illana A; Cazorla-Luna R; Sarmento B; Ruiz-Caro R; das Neves J; Veiga MD Acta Biomater; 2021 Feb; 121():316-327. PubMed ID: 33333257 [TBL] [Abstract][Full Text] [Related]
79. Co-emulsified Alginate-Eudragit Nanoparticles: Potential Carriers for Localized and Time-defined Release of Tenofovir in the Female Genital Tract. Takalani F; Kumar P; Kondiah PPD; Choonara YE AAPS PharmSciTech; 2024 Jan; 25(1):15. PubMed ID: 38200167 [TBL] [Abstract][Full Text] [Related]